Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank89
5Y CAGR+120.1%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
+120.1%/yr
Long-term compound
Percentile
P89
Within normal range
vs 5Y Ago
51.6x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025565.89%
202410.23%
2023-47.30%
2022-27.94%
20215134.06%
202010.96%
2019-1167.36%
20180.00%
20170.00%
20160.00%